Trial Profile

An Open Label, Dose Escalation Study to Evaluate the Safety and Efficacy of Intralesional Injection of STP705 in Adult Patients With Cutaneous Squamous Cell Carcinoma in Situ (isSCC)

Status: Completed

Phase of Trial: Phase I/II

Latest Information Update: 10 Jun 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs STP 705 (Primary)
Indications Skin cancer; Squamous cell cancer
Focus Therapeutic Use
Sponsors Sirnaomics

Most Recent Events

18 Oct 2021 According to a Sirnaomics media release, data from this trial will be presented at the 2021 Fall Clinical Dermatology Conference.
22 Sep 2021 According to a Sirnaomics media release, positive results from this trial will be at the 2021 TIDES USA event.
25 Apr 2021 Results presented in a Sirnaomics media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com